Alzheimer’s Association International Conference 2024
The Alzheimer’s Association International Conference (AAIC) is the largest international meeting dedicated to advancing dementia science and clinical practice. Each year, AAIC convenes researchers, clinicians and dementia professionals from all career stages to share breaking research discoveries and clinical practice education that will lead to improvements in diagnosis, risk reduction and treatments for Alzheimer’s disease and other dementia. From basic science to dementia care, every aspect of the field’s growing knowledge of dementia is incorporated into this world-class conference.
Discover the latest Alzheimer’s research authored and presented by the Clario science team at AAIC ’24. Stay informed on groundbreaking advancements in imaging methodologies, and learn about industry trends in electronic clinical outcomes assessments. This research could lead to meaningful progress in the fight against Alzheimer’s disease. Be sure to attend our poster sessions to hear the latest!
Poster session information:
Poster title: Impact of AI-based segmentation on PET analyses
Poster #: 89228
Authors: Luc Bracoud, M. Sc.; Joyce Suhy, Ph.D.; Thomas Cajgfinger, Ph.D.; Olivier Rousset, Ph.D.; Madhura Ingalhalikar, Ph.D.; Chris Conklin, Ph.D.; Manja Lehmann, Ph.D.; Joel Schaerer, Ph.D.; David Scott, Ph.D.
Date: Saturday, July 27
Poster title: Low Incidence of Amyloid Related Imaging Abnormalities over 104 Weeks in a Phase 2 Study of Amyloid Anti-Oligomer Agent ALZ-801: Phase 2 Study Results in Biomarker Positive APOE4 Carriers with Early Alzheimer’s Disease (AD)
Poster #: 92653
Authors: Patrick Kesslak, Ph.D.; Susan Abushakra, M.D.; Luc Bracoud, M.Sc.; Joyce Suhy, Ph.D.; John A. Hey, Ph.D.; Jerome Barakos, M.D.; Jakub Hort, Ph.D., M.D.; Niels D. Prins, Ph.D., M.D.; Aidan Power, M.D. and Martin Tolar, M.D., Ph.D.
Date: Tuesday, July 30
Poster title: Plasma Biomarkers, Hippocampal Volume and Cognitive Effects of Oral ALZ-801: The Phase 2 Biomarker Study and its Long-Term Extension in APOE4 Carriers with Early Alzheimer’s Disease
Poster #: 92548
Authors: Susan Abushakra, M.D.; John A. Hey, Ph.D.; Kaj Blennow, M.D., Ph.D.; Jakub Hort, MD Ph.D.; Niels D. Prins, Ph.D., M.D.; Patrick Kesslak, Ph.D.; Winnie Pak; Larry Shen, Ph.D.; Xinyi Zhu; Caiyan Li; Adem Albayrak; Luc Bracoud, M.Sc.; Joyce Suhy, Ph.D.; Aidan Power, M.D. and Martin Tolar, M.D., Ph.D.
Date: Wednesday, July 31
Poster title: Trends in Alzheimer’s Disease clinical outcome assessments in phase 2 and 3 clinical trials from 1993 to present
Authors: Sarah T Gary, Ph.D.; Reina Davis-Aoki, Ph.D.; Prateek Verma, M.D. and Bryan McDowell, M.B.A.
Date: Wednesday, July 31